Etoposide and myelodysplastic syndrome Patient Reports February 12, 2012

Etoposide Side Effects Report #5016436-4
Etoposide side effect was reported by a Health Professional from JAPAN on Mar 07, 2006. Female patient, 27 years of age, was diagnosed with stem cell transplant, lymphoma  and was treated with Etoposide. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome, platelet count decreased, treatment related secondary malignancy. Etoposide dosage: unknown. During the same period patient was treated with PARAPLATIN, NIDRAN, TESPAMIN. Patient recovered.

Etoposide Side Effects Report #5491828-8
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 01, 2007. Male patient, 50 years of age, was diagnosed with b-cell lymphoma and was treated with Etoposide. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome. Etoposide dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE, IODINE, RITUXIMAB, IFOSFAMIDE, CARBOPLATIN. Patient recovered.

Etoposide Side Effects Report #5492073-2
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 01, 2007. Male patient, 50 years of age, was diagnosed with b-cell lymphoma and was treated with Etoposide. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome, thrombocytopenia. Etoposide dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE, IODINE, RITUXIMAB, IFOSFAMIDE, CARBOPLATIN. Patient recovered.

Etoposide Side Effects Report #5781347-3
Etoposide side effect was reported by a Health Professional from UNITED STATES on June 16, 2008. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cytogenetic abnormality, myelodysplastic syndrome. Etoposide dosage: unknown. During the same period patient was treated with CYTARABINE, NEUPOGEN, DAUNORUBICIN, MELPHALAN, MITOXANTRONE. Patient died.


Etoposide Side Effects Report #5797753-7
Etoposide side effect was reported by a Health Professional from UNITED STATES on June 19, 2008. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: cytogenetic abnormality, leukaemia recurrent, myelodysplastic syndrome. Etoposide dosage: 100 MG/M**2; DAILY;. During the same period patient was treated with MITOXANTRONE, CYTARABINE, DAUNORUBICIN, MELPHALAN. Patient died.

Etoposide Side Effects Report #5781343-6
Etoposide side effect was reported by a Health Professional from UNITED STATES on June 16, 2008. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: cytogenetic abnormality, myelodysplastic syndrome. Etoposide dosage: unknown. During the same period patient was treated with CYTARABINE, BUSULFAN, NEUPOGEN, DAUNORUBICIN, FLUDARABINE, MELPHALAN. Patient recovered.

Etoposide Side Effects Report #5797752-5
Etoposide side effect was reported by a Health Professional from UNITED STATES on June 19, 2008. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, complications of transplant surgery, myelodysplastic syndrome, stem cell transplant. Etoposide dosage: 100 MG/M**2; DAILY;. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, BUSULFAN. Patient died.

Etoposide Side Effects Report #5781348-5
Etoposide side effect was reported by a Health Professional from UNITED STATES on June 16, 2008. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: cytogenetic abnormality, myelodysplastic syndrome. Etoposide dosage: unknown. During the same period patient was treated with CYTARABINE, LEUKINE, DAUNORUBICIN, IDARUBICIN. Patient recovered.

Etoposide Side Effects Report #5797754-9
Etoposide side effect was reported by a Health Professional from UNITED STATES on June 19, 2008. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: cytogenetic abnormality, myelodysplastic syndrome. Etoposide dosage: 100 MG/M**2; DAILY. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, IDARUBICIN. Patient recovered.


Etoposide Side Effects Report #5781346-1
Etoposide side effect was reported by a Health Professional from UNITED STATES on June 16, 2008. Male patient, 42 years of age, was diagnosed with acute myeloid leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cytogenetic abnormality, myelodysplastic syndrome. Etoposide dosage: unknown. During the same period patient was treated with CYTARABINE, NEUPOGEN, IDARUBICIN, MELPHALAN, MITOXANTRONE. Patient recovered.

Etoposide Side Effects Report #4545933-0
Etoposide side effect was reported by a Consumer or non-health professional from on Sept 09, 2004. Female patient, 41 years of age, was diagnosed with acute myeloid leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cerebral haemorrhage, myelodysplastic syndrome, treatment related secondary malignancy. Etoposide dosage: unknown. During the same period patient was treated with ENDOXAN, BLEOMYCIN SULPHATE, CISPLATIN, CARBOPLATIN, ADRIAMYCIN PFS, VINCRISTINE. Patient was hospitalized. Patient died on 03/01/2002.